Company / CapEx per Share
NewAmsterdam Pharma Co N.V. CapEx per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2025
5-year range
$0.00 / $0.01
FY2021-FY2025
Trend
-70.8%
vs FY2024
Sector context
#162 of 191
Health Care
What the data says
NewAmsterdam Pharma Co N.V.'s capex per share of $0.00 is lower than 85% of companies in the Health Care sector (FY2025). CapEx per Share has fluctuated over the past 5 years, ranging from $0.00 in FY2023 to $0.01 in FY2022.
Based on SEC 10-K filings.
0.00 in FY2025 with a 3-year CAGR of -43.7%.
Improved from $0.00 to $0.00 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -43.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 191This company $0.00 Sector average $4.05
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 70.8% year-over-year.
- Ranks #162 out of 191 companies in the Health Care sector.
- Peak capex per share was recorded in FY2022.
- Lowest capex per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | -70.8% |
| FY2024 | $0.01 | +2338.1% |
| FY2023 | $0.00 | -97.5% |
| FY2022 | $0.01 | +433.0% |
| FY2021 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026